These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22280408)

  • 41. Colorectal cancer population screening programs worldwide in 2016: An update.
    Navarro M; Nicolas A; Ferrandez A; Lanas A
    World J Gastroenterol; 2017 May; 23(20):3632-3642. PubMed ID: 28611516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
    Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [National colorectal carcinoma screening program deserves further study; a report from the Dutch Health Council].
    van Veen WA
    Ned Tijdschr Geneeskd; 2001 Aug; 145(34):1655-7. PubMed ID: 11552370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of a colonoscopic screening examination for colorectal cancer on later utilization of distal GI endoscopies.
    Thiis-Evensen E; Seip B; Vatn MH; Hoff GS
    Gastrointest Endosc; 2006 Dec; 64(6):948-54. PubMed ID: 17140903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1).
    Adler A; Roll S; Marowski B; Drossel R; Rehs HU; Willich SN; Riese J; Wiedenmann B; Rösch T;
    Dis Colon Rectum; 2007 Oct; 50(10):1628-38. PubMed ID: 17694415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
    Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study.
    van Toledo DEFWM; IJspeert JEG; Bossuyt PMM; Bleijenberg AGC; van Leerdam ME; van der Vlugt M; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):747-754. PubMed ID: 35550250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
    van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
    United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resource implications for a population-based colorectal cancer screening program in Canada: a study of the impact on colonoscopy capacity and costs in London, Ontario.
    Lau A; Gregor JC
    Can J Gastroenterol; 2007 Jun; 21(6):371-7. PubMed ID: 17571171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of efficacy and cost-effectiveness when screening colonoscopy is performed by nongastroenterologists.
    Hassan C; Rex DK; Zullo A; Cooper GS
    Cancer; 2012 Sep; 118(18):4404-11. PubMed ID: 22707430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.
    Ribbing Wilén H; Saraste D; Blom J
    J Med Screen; 2022 Sep; 29(3):156-165. PubMed ID: 35257615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
    Stock C; Brenner H
    Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
    Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
    Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database.
    Lantinga MA; Theunissen F; Ter Borg PCJ; Bruno MJ; Ouwendijk RJT; Siersema PD;
    Endoscopy; 2021 Feb; 53(2):166-170. PubMed ID: 33080630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors to Improve Endoscopic Screening for Colorectal Cancer.
    Malgazhdarov MS; Madyarov VM; Kaliaskarov YS; Kaliyeva ZZ; Isabekov NA
    J Gastrointest Cancer; 2021 Mar; 52(1):289-293. PubMed ID: 32303997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colonoscopy Needs for Implementation of a Colorectal Cancer Screening Program in Ukraine.
    Welten VM; Wanis KN; Semeniv S; Shabat G; Dabekaussen KFAA; Davids JS; Beznosenko A; Suprun U; Soeteman DI; Melnitchouk N
    World J Surg; 2022 Oct; 46(10):2476-2486. PubMed ID: 35835863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.